Tech Company Financing Transactions
Sitka Biopharma Funding Round
Sitka Biopharma, based in Vancouver BC, secured $1.9 million from Global Health Sciences Fund.
Transaction Overview
Company Name
Announced On
10/26/2018
Transaction Type
Venture Equity
Amount
$1,900,000
Round
Undisclosed
Investors
Global Health Sciences Fund (Karimah Sabar)
Proceeds Purpose
The financing that will enable the company to complete critical GLP toxicology studies and GMP manufacture of clinical drug product.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2405 Wesbrook Mall 4th Floor
Vancouver BC, V6T 1Z3
Canada
Vancouver BC, V6T 1Z3
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Richard Liggins
President
Michael Parr
Browse more venture capital transactions:
Prev: 10/26/2018: Area 1 Security venture capital transaction
Next: 10/26/2018: Lorem venture capital transaction
Share this article
Where The Data Comes From
We record funding rounds that are announced publicly. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs